Chris Wraight is the Chief Executive Officer of MecRx.
Richard Foitzik is Head of Medicinal Chemistry. Richard is responsible for the direction and implementation of MecRx’s therapeutic programs.
Jo Alcindor is a Founder of MecRx, Director and Chief Operations Officer. Jo is responsible for the management of MecRx's research programs and company operations.
Professor Ricky Johnstone is Assistant Director of Research at the Peter Maccallum Cancer centre and a co-founder of the Cancer Therapuetics Program within PeterMac. Professor Johnstone leads the cMyc biology progam at MecRx.
Paul Savage is Research Director of the Biomedical Manufacturing Program at CSIRO and MecRx board observer. His role in establishing the CSIRO/MecRx collaboration has been pivotal to the success of the Technology.
Chris Smith is an Investment Manager at Brandon Capital Partners and MecRx Director. Brandon Capital Partners make seed and venture capital investments for the development and international growth of Australian life science companies.